How fixed costs lifted Vimera Specialistvård's operating profit 769.3%

Profit ran far ahead of a strong year for sales

Vimera Specialistvård AB is a Swedish limited company (AB stands for aktiebolag) working in specialist care, as its name says. In the financial year that ran from April 2025 to March 2026 it booked revenue of SEK 130m, up 94.4% from SEK 66.9m a year earlier. The figures cover the company on its own, in Swedish kronor. That alone would make it a remarkable year.

Operating profit moved much further. It rose from SEK 1.6m to SEK 13.6m, an increase of 769.3%. Measured against the rise in revenue, operating profit grew about 8.15× as fast. The operating margin, the share of each krona of revenue left after paying for the running of the business, widened from 2.3% to 10.5%, a gain of 8.1 pp.

In a business that mostly sells the time of skilled people, margins tend to be thin, and a jump of this size is unusual. That is the tension. The 2026 result looks like a different company from the 2025 one, but the thing that produced the jump is a property of the cost base, and it does not care which direction revenue moves.

Why each extra krona went further

A care provider carries costs of different kinds. Some rise with every patient or every booked hour: consumables, hired clinicians paid by the shift, some lab and transport costs. Others stay put whether the calendar is full or half empty: premises, management, administration, IT systems, insurance, the people who schedule the clinicians and send the invoices. Once revenue covers that fixed block, most of each additional krona falls to operating profit.

Vimera did not grow without adding people. Its headcount rose from 46 to 72. Staff are the largest cost in care, so this was not a year of free growth. But revenue rose faster than the workforce: revenue per employee climbed 24.2%, from SEK 1.5m to SEK 1.8m. Each person on the payroll carried more of the business, and the overheads above them were spread across a much larger turnover.

There are several ways this can happen in specialist care. Clinicians' schedules can fill up, so the same salaried doctor sees more patients. A new contract with a region can bring volume into rooms and systems that already existed. Prices can rise. Or part of the work can be done by hired clinicians from staffing agencies, who appear in the accounts as an external service rather than as employees. The accounts do not say which of these drove the year. The cost of external staff, set against personnel costs for both years, would show whether the gain in revenue per employee is real productivity or work moved to another line of the income statement.

The difference matters. A fuller schedule tends to last as long as demand does. A price rise or a new contract can disappear at the next tender. Agency staff are a variable cost: they make the business less exposed to a downturn, but they also make the productivity figure look better than the underlying efficiency.

Most of the gain stopped short of the bottom line

The lever is clearest at the operating line. Below it, the picture is quieter. Net profit rose from SEK 3.7k to SEK 3.3m, which leaves a net margin of 2.5% against an operating margin of 10.5%. A large slice of the operating profit went somewhere between the two lines: interest, tax, or the year-end appropriations Swedish companies can book to move profit between years or to other group companies. The accounts do not split that gap, and until it is clear I would not call this a step change in what owners keep.

The balance sheet improved, but from a thin base. Equity rose from SEK 6.3m to SEK 9.6m, by SEK 3.3m, which matches the year's net profit: the company kept what it earned. Its equity ratio, equity as a share of everything it holds, went from 15.0% to 16.8%. Total assets stood at SEK 56.8m, so most of the balance sheet is still financed by lenders, suppliers and other creditors. Cash rose to SEK 4.9m from almost nothing a year earlier.

That buffer is what has to absorb the reverse of this year's lever. A company with so little of its balance sheet in equity has limited room if a strong operating margin shrinks back toward where it was in 2025.

The lever has a reverse gear

The same arithmetic that turned a strong rise in revenue into a much stronger rise in operating profit works on the way down. If revenue falls and the premises, management and salaried clinicians stay, the lost revenue comes almost entirely out of operating profit. A drop in sales that looks manageable on the top line can take a large share of the margin with it.

This is one year's movement, not a trend. A year in which revenue grew this fast can include one-off effects: a new contract, a clinic that opened partway through the previous year, a catch-up in patient volumes. I would not read the 10.5% operating margin as the company's new normal until another year confirms it.

What to check in your own company

If your business carries premises, salaried specialists and a management layer, the same lever sits inside your income statement. You can measure it with last year's accounts and an afternoon.

Start by sorting your operating costs into a fixed list and a variable list. Use contracts, not account names. A lease that runs for years is fixed. A salaried employee is fixed until notice runs out. A clinician or contractor paid per shift or per job is variable.

Then take revenue minus the variable costs. That is your contribution, the money left to pay the fixed costs. Divide your operating profit by that contribution. The result is the share by which revenue could fall before operating profit reaches zero, assuming fixed costs do not move. If the answer is small, a slow quarter will hurt more than the sales figure suggests.

Finally, if revenue per employee is one of your measures of efficiency, track it next to the cost of subcontractors and agency staff. When both rise together, the efficiency may be a cost that changed address.

Vimera Specialistvård had an outstanding year at the operating line, and most of it came from spreading a cost base over far more revenue. The business did not become safer in the process. With thin equity and a lever that points both ways, the revenue line of the next financial year matters more to this company than this year's profit does.